Ready to pay "reasonable" royalty to Novartis AG: Cipla to HC
Indian pharma firm Cipla Monday suggested to the Delhi High Court that it was ready to pay "reasonable" royalty to Switzerland-based drug major Novartis AG if it is allowed to manufacture respiratory disease drug, 'Indaflo', which could serve 66,000 patients in India at a cheaper rate.
Apr 27, 2015, 23:21 PM ISTHC restrains Cipla from selling drug containing Indacaterol
The court said the restraint on Cipla will remain till its application for compulsory license is decided by the relevant authority.
Jan 09, 2015, 23:51 PM IST